These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7225581)

  • 1. Spontaneous lymphocyte transformation in relation to the number of circulating lymphocytes in Hodgkin's disease.
    de Mulder PH; de Pauw BE; Wagener DJ; Haanen C
    Blut; 1981 Apr; 42(4):249-52. PubMed ID: 7225581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease.
    Björkholm M; Askergren J; Wedelin C; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jul; 25(1):51-7. PubMed ID: 6969422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous transformation of low density lymphocytes as parameter of activity in Hodgkin's disease.
    de Pauw BE; de Mulder PH; Smeulders JB; Wagener DJ; Haanen C
    Scand J Haematol; 1980 Jul; 25(1):58-62. PubMed ID: 7444374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneously DNA synthesizing blood and spleen lymphocytes in Hodgkin's disease.
    Björkholm M; Holm G; Ljungdahl A; Strömberg M; Askergren J
    Scand J Haematol; 1981 Feb; 26(2):97-105. PubMed ID: 7256215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease.
    Sugden PJ; Lilleyman JS
    Cancer; 1980 Mar; 45(5):899-905. PubMed ID: 7260841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte density distribution profile and spontaneous transformation related to the stage of Hodgkin's disease.
    de Pauw BE; Wagener DJ; Smeulders JB; Geestman EJ; Wessels JM; Haanen C
    Br J Haematol; 1980 Mar; 44(3):359-64. PubMed ID: 7378305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
    Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
    Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
    Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
    Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the immune status of patients with Hodgkin's disease on the basis of determination of the T and B lymphocyte proportion in peripheral blood, spleen and lymph nodes and the determination of their mitogen-induced blastic transformation].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Aug; 58(2):189-95. PubMed ID: 302938
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic profile of patients with cured Hodgkin's disease.
    Bjorkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte function in Hodgkin's Disease.
    Benninghoff DL; Girardet R
    Lymphology; 1976 Mar; 9(1):39-42. PubMed ID: 1263573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.